tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: T2 Biosystems (TTOO) and Axsome Therapeutics (AXSM)

Analysts fell to the sidelines weighing in on T2 Biosystems (TTOOResearch Report) and Axsome Therapeutics (AXSMResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

T2 Biosystems (TTOO)

T2 Biosystems received a Hold rating and a $2.50 price target from Canaccord Genuity analyst Kyle Mikson CFA today. The company’s shares closed last Thursday at $2.55, close to its 52-week low of $2.06.

According to TipRanks.com, CFA has 0 stars on 0-5 stars ranking scale with an average return of -29.0% and a 13.4% success rate. CFA covers the Healthcare sector, focusing on stocks such as Pacific Biosciences, Guardant Health, and NanoString Tech.

Currently, the analyst consensus on T2 Biosystems is a Hold with an average price target of $2.50, which is a 6.4% upside from current levels. In a report issued on October 12, BTIG also reiterated a Hold rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

Axsome Therapeutics (AXSM)

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Axsome Therapeutics, with a price target of $74.00. The company’s shares closed last Thursday at $46.21.

According to TipRanks.com, Purohit ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -25.0% and a 17.0% success rate. Purohit covers the Healthcare sector, focusing on stocks such as Arcutis Biotherapeutics, Theravance Biopharma, and Foghorn Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Axsome Therapeutics with a $96.38 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on TTOO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles